BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 17999989)

  • 1. Polymorphic variants in PTGS2 and prostate cancer risk: results from two large nested case-control studies.
    Danforth KN; Hayes RB; Rodriguez C; Yu K; Sakoda LC; Huang WY; Chen BE; Chen J; Andriole GL; Calle EE; Jacobs EJ; Chu LW; Figueroa JD; Yeager M; Platz EA; Michaud DS; Chanock SJ; Thun MJ; Hsing AW
    Carcinogenesis; 2008 Mar; 29(3):568-72. PubMed ID: 17999989
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TNF polymorphisms and prostate cancer risk.
    Danforth KN; Rodriguez C; Hayes RB; Sakoda LC; Huang WY; Yu K; Calle EE; Jacobs EJ; Chen BE; Andriole GL; Figueroa JD; Yeager M; Platz EA; Michaud DS; Chanock SJ; Thun MJ; Hsing AW
    Prostate; 2008 Mar; 68(4):400-7. PubMed ID: 18196539
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Meta-analysis of epidemiological studies demonstrates significant association of PTGS2 polymorphism rs689470 and no significant association of rs20417 with prostate cancer.
    Zhang HT; Xu Y; Zhang ZH; Li L
    Genet Mol Res; 2012 Jun; 11(2):1642-50. PubMed ID: 22782583
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic Value of Prostaglandin-endoperoxide Synthase 2 Polymorphisms in Prostate Cancer Recurrence after Radical Prostatectomy.
    Lee CH; Pao JB; Lu TL; Lee HZ; Lee YC; Liu CC; Huang CY; Lin VC; Yu CC; Yin HL; Huang SP; Bao BY
    Int J Med Sci; 2016; 13(9):696-700. PubMed ID: 27647999
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A polymorphism in the 3' untranslated region of the gene encoding prostaglandin endoperoxide synthase 2 is not associated with an increase in breast cancer risk: a nested case-control study.
    Cox DG; Buring J; Hankinson SE; Hunter DJ
    Breast Cancer Res; 2007; 9(1):R3. PubMed ID: 17214885
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prostaglandin-endoperoxide synthase 2 (PTGS2) gene polymorphisms and risk of biliary tract cancer and gallstones: a population-based study in Shanghai, China.
    Sakoda LC; Gao YT; Chen BE; Chen J; Rosenberg PS; Rashid A; Deng J; Shen MC; Wang BS; Han TQ; Zhang BH; Cohen-Webb H; Yeager M; Welch R; Chanock S; Fraumeni JF; Hsing AW
    Carcinogenesis; 2006 Jun; 27(6):1251-6. PubMed ID: 16361272
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PTGS2 and IL6 genetic variation and risk of breast and prostate cancer: results from the Breast and Prostate Cancer Cohort Consortium (BPC3).
    Dossus L; Kaaks R; Canzian F; Albanes D; Berndt SI; Boeing H; Buring J; Chanock SJ; Clavel-Chapelon F; Feigelson HS; Gaziano JM; Giovannucci E; Gonzalez C; Haiman CA; Hallmans G; Hankinson SE; Hayes RB; Henderson BE; Hoover RN; Hunter DJ; Khaw KT; Kolonel LN; Kraft P; Ma J; Le Marchand L; Lund E; Peeters PH; Stampfer M; Stram DO; Thomas G; Thun MJ; Tjonneland A; Trichopoulos D; Tumino R; Riboli E; Virtamo J; Weinstein SJ; Yeager M; Ziegler RG; Cox DG
    Carcinogenesis; 2010 Mar; 31(3):455-61. PubMed ID: 19965896
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of prostaglandin-endoperoxide synthase 2 (PTGS2) polymorphisms and Alzheimer's disease in Chinese.
    Ma SL; Tang NL; Zhang YP; Ji LD; Tam CW; Lui VW; Chiu HF; Lam LC
    Neurobiol Aging; 2008 Jun; 29(6):856-60. PubMed ID: 17234302
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association between the 8473T>C polymorphism of PTGS2 and prostate cancer risk: a metaanalysis including 24,716 subjects.
    Yang X; Li B; Si T; Liu Y; Guo Z
    Onkologie; 2013; 36(4):182-6. PubMed ID: 23548966
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polymorphic variants in alpha-methylacyl-CoA racemase and prostate cancer.
    Daugherty SE; Shugart YY; Platz EA; Fallin MD; Isaacs WB; Pfeiffer RM; Welch R; Huang WY; Reding D; Hayes RB
    Prostate; 2007 Oct; 67(14):1487-97. PubMed ID: 17680641
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prostate genetic score (PGS-33) is independently associated with risk of prostate cancer in the PLCO trial.
    Liss MA; Xu J; Chen H; Kader AK
    Prostate; 2015 Sep; 75(12):1322-8. PubMed ID: 25982801
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic variation in the COX-2 gene and the association with prostate cancer risk.
    Shahedi K; Lindström S; Zheng SL; Wiklund F; Adolfsson J; Sun J; Augustsson-Bälter K; Chang BL; Adami HO; Liu W; Grönberg H; Xu J
    Int J Cancer; 2006 Aug; 119(3):668-72. PubMed ID: 16506214
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Role of Genetic Variants in the Association between Dietary Acrylamide and Advanced Prostate Cancer in the Netherlands Cohort Study on Diet and Cancer.
    Perloy A; Schouten LJ; van den Brandt PA; Godschalk R; van Schooten FJ; Hogervorst JGF
    Nutr Cancer; 2018; 70(4):620-631. PubMed ID: 29697282
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polymorphisms in angiogenesis-related genes and prostate cancer.
    Jacobs EJ; Hsing AW; Bain EB; Stevens VL; Wang Y; Chen J; Chanock SJ; Zheng SL; Xu J; Thun MJ; Calle EE; Rodriguez C
    Cancer Epidemiol Biomarkers Prev; 2008 Apr; 17(4):972-7. PubMed ID: 18398039
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A genetic polymorphism in prostaglandin synthase 2 (8473, T-->C) and the risk of lung cancer.
    Sørensen M; Autrup H; Tjønneland A; Overvad K; Raaschou-Nielsen O
    Cancer Lett; 2005 Aug; 226(1):49-54. PubMed ID: 15882925
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of prostaglandin-endoperoxide synthase 2 gene polymorphisms with asthma and atopy in Chinese children.
    Chan IH; Tang NL; Leung TF; Ma SL; Zhang YP; Wong GW; Wong CK; Lam CW
    Allergy; 2007 Jul; 62(7):802-9. PubMed ID: 17573729
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polymorphisms in COX-2 gene influence prostate cancer susceptibility in a northern Indian cohort.
    Mandal RK; Mittal RD
    Arch Med Res; 2011 Oct; 42(7):620-6. PubMed ID: 22023987
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Profiling of genetic variations in inflammation pathway genes in relation to bladder cancer predisposition.
    Yang H; Gu J; Lin X; Grossman HB; Ye Y; Dinney CP; Wu X
    Clin Cancer Res; 2008 Apr; 14(7):2236-44. PubMed ID: 18381966
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pyrosequencing of polymorphisms in the COX-2 gene (PTGS2) with reported clinical relevance.
    Skarke C; Schuss P; Kirchhof A; Doehring A; Geisslinger G; Lötsch J
    Pharmacogenomics; 2007 Dec; 8(12):1643-60. PubMed ID: 18085997
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Current evidence on the relationship between polymorphisms in the COX-2 gene and breast cancer risk: a meta-analysis.
    Yu KD; Chen AX; Yang C; Qiu LX; Fan L; Xu WH; Shao ZM
    Breast Cancer Res Treat; 2010 Jul; 122(1):251-7. PubMed ID: 20033767
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.